BIG-Annotator:基因组测序数据高效功能注释及其在遗传诊断中的应用
收稿日期: 2018-09-29
修回日期: 2018-11-02
网络出版日期: 2018-11-06
基金资助
国家自然科学基金项目(31571370);国家自然科学基金项目(91631106);中国科学院“百人计划”项目资助
Application of BIG-Annotator in the genome sequencing data functional annotation and genetic diagnosis
Received date: 2018-09-29
Revised date: 2018-11-02
Online published: 2018-11-06
Supported by
Supported by the National Natural Science Foundation of China(31571370);Supported by the National Natural Science Foundation of China(91631106);the “Hundred Talents Program” of Chinese Academy of Sciences
近年来二代测序技术发展迅速,在精准医疗和遗传诊断上得到日益广泛的应用。对二代测序数据进行分析的一个核心环节是对遗传变异位点的识别和注释。基于此,本课题组开发了一个能高效对全基因组单核苷酸多态位点进行功能注释的软件——BIG-Annotator。该软件以JAVA语言编写,且提供多线程运行模式,运行更为高效,比现有的同类软件或流程提速10多倍,适用于人群队列研究、大样本全基因组关联分析等数据量庞大、时效性要求高的分析需求。同时,该软件还集成了目前常用的二代测序遗传变异注释数据库,以及临床数据解读与报告的标准指南(2015 ACMG-AMP《解读报告标准指南》),并且增加了针对肿瘤组织遗传变异注释的信息。最后,通过两个研究实例具体说明该软件在遗传诊断中的应用。
黄莹,刘琪,池连江,石承民,吴祯,胡敏,石宏,陈华 . BIG-Annotator:基因组测序数据高效功能注释及其在遗传诊断中的应用[J]. 遗传, 2018 , 40(11) : 1015 -1023 . DOI: 10.16288/j.yczz.18-274
The next generation sequencing (NGS) technology has been playing important roles in genetic diagnosis of diseases in recent years, and serving as a technological basis of precision medicine. In analyzing NGS data, the variant annotation is an important step. In this study, we developed a computationally efficient software (BIG-Annotator) to perform functional annotation for whole-genome single nucleotide polymorphisms. BIG-Annotator integrates the widely used databases and pipelines for variant annotation of genetic diseases and tumors, and follows the 2015 ACMG-AMP Standard Guide for Interpretation and Reporting of Clinical Variants. BIG-Annotator is ten times faster than the existing software, and suitable for annotating genomic sequencing data from large samples. Here we present two analysis cases of genetic diagnosis using BIG-Annotator to show its applications.
Key words: NGS; variant annotation; genetic diagnosis; precision medicine
| [1] | Mirnezami R, Nicholson J, Darzi A . Preparing for precision medicine. N Engl J Med, 2012,366(6):489-491. |
| [2] | Middha S. Bioinformatics solution for clinical utilization of next generation DNA sequencing[Dissertation]. 2014, . |
| [3] | Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res, 2010,38(16):e164. |
| [4] | Li Q, Wang K . InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet, 2017,100(2):267-280. |
| [5] | Altshuler D . A map of human genome variation from population-scale sequencing. Nature, 2010,467(7319):1061-1073. |
| [6] | ACMG Board of Directors . ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med, 2015,17(1):68-69. |
| [7] | Landrum MJ, Lee JM, Riley GR, Jang E, Rubinstein WS, Church DM, Maglott DR . ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res, 2014,42(Database issue):D980-985. |
| [8] | Krawczak M, Ball EV, Fenton I, Stenson PD, Abeysinghe S, Thomas N, Cooper DN . Human gene mutation database-a biomedical information and research resource. Hum Mutat, 2015,15(1):45-51. |
| [9] | Slavin TP, Van Tongeren LR, Behrendt CE, Solomon I, Ryback C, Nehoray B, Kuzmich L, Niell-Swiller M, Blazer KR, Tao S, Yang K, Culver JO, Sand S, Castillo D, Herzog J, Gray SW, Weitzel JN . Prospective study of cancer genetic variants: variation in rate of reclassification by ancestry. J Natl Cancer Inst, 2018,110(10):1059-1069. |
| [10] | Monti E, Mottes M, Fraschini P, Brunelli P, Forlino A, Venturi G, Doro F, Perlin S, Cavarzere P, Antoniazzi F . Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag, 2010,6(2):367-381. |
| [11] | Kataoka K, Ogura E, Hasegawa K, Inoue M, Seino Y, Morishima T, Tanaka H . Mutations in type I collagen genes in Japanese osteogenesis imperfecta patients. Pediatr Int, 2010,49(5):564-569. |
/
| 〈 |
|
〉 |